Elisa Agostinetto and Giuseppe Curigliano discuss the results of Destiny-Breast06

Elisa Agostinetto shared on LinkedIn:

“At ASCO24 I met Prof Giuseppe Curigliano to discuss the results of Destiny-Breast06 on T-DXd in HER2-low and ultra low breast cancer

We discussed implications for clinical practice, future perspectives and tips to manage ILD.”.

Read further
Source: Elisa Agostinetto/LinkedIn

Dr. Elisa Agostinetto, is a medical oncologist, specializing in breast cancer research. Trained in Milan, Italy, she currently conducts advanced research at Institut Jules Bordet – Université Libre de Bruxelles in Brussels, Belgium. Actively engaged in professional societies like ESMO, ASCO, and BSMO, she also contributes as a young investigator in the EORTC Breast Cancer Working Group and as a Committee member of the Young Cancer Professionals within the European Cancer Organization.